-
公开(公告)号:EP4440735A1
公开(公告)日:2024-10-09
申请号:EP22830405.1
申请日:2022-12-01
申请人: Vilnius University
CPC分类号: B01J13/046 , B01J13/14 , A61K2035/1120130101 , C12N5/0012 , C12N2533/5420130101 , C12N2533/4020130101 , C12N2513/0020130101 , C12N15/88 , C12N11/04 , C12N11/02 , C12N1/04 , A61K9/5057 , A61K9/5036 , A61K47/42 , A61K47/32 , A61K47/10
-
公开(公告)号:EP4402247A1
公开(公告)日:2024-07-24
申请号:EP22789868.1
申请日:2022-09-13
申请人: The University Court Of The University Of Glasgow , Imperial College Innovations Limited , CELLINK Bioprinting AB
发明人: DOBRE, Oana , TRUJILLO-MUÑOZ, Sara , DALBY, Matthew John , SALMERON-SANCHEZ, Manuel , OUYANG, Liliang , STEVENS, Molly , REDWAN, Adel Itedal Namro , KUZMENKO, Volodymyr , GATENHOLM, Erik , MARTÍNEZ, Héctor
IPC分类号: C12N5/00
CPC分类号: C12N5/0068 , C12N2533/5420130101 , C12N2533/5220130101
-
公开(公告)号:EP4397751A1
公开(公告)日:2024-07-10
申请号:EP23305007.9
申请日:2023-01-04
IPC分类号: C12N5/071
CPC分类号: C12N5/0626 , C12N2506/0220130101 , C12N2506/4520130101 , C12N2533/9020130101 , C12N2533/5420130101 , C12N2501/12520130101 , C12N2501/15520130101 , C12N2501/36520130101 , C12N2501/41520130101 , C12N2501/72720130101
摘要: The present invention pertains to in vitro methods for obtaining a population of mature and functional human melanocytes from human pluripotent stem cells (hPSC) and to uses of said population. The method according to the present invention comprises a differentiation step wherein neural crest cells are cultured in presence of a GSK3 inhibitor such as CHIR99021 or WNT3A, BMP4, AA, SCF and EDN3.
-
公开(公告)号:EP4377442A1
公开(公告)日:2024-06-05
申请号:EP22847766.7
申请日:2022-07-29
申请人: Spiderwort Inc.
-
5.
公开(公告)号:EP4367218A2
公开(公告)日:2024-05-15
申请号:EP22838158.8
申请日:2022-06-30
IPC分类号: C12N5/00 , C12N5/0775
-
公开(公告)号:EP4421158A1
公开(公告)日:2024-08-28
申请号:EP23305244.8
申请日:2023-02-23
申请人: SARTORIUS STEDIM FMT SAS , UNIVERSITE CLAUDE BERNARD - LYON 1 , Institut National des Sciences Appliquées de Lyon , Ecole Superieure de Chimie Physique Electronique de Lyon , Centre National de la Recherche Scientifique
发明人: Petiot, Emma , Chocarro , Courtial, Edwin-Joffrey
IPC分类号: C12M1/12 , C12M1/26 , C12N5/00 , C12N11/04 , B29C64/112
CPC分类号: C12M25/16 , C12M27/02 , C12M33/00 , C12N5/0075 , C12N11/04 , B29C64/112 , B33Y80/00 , C12N5/0667 , C12N2533/5420130101 , C12N2533/7420130101 , C12N2533/8020130101 , C12N2537/1020130101
摘要: Methods for producing microcarriers by ink jetting, comprising propelling a droplet of a solution comprising one or more biomaterials capable of forming a hydrogel and one or more cells, into a liquid medium. Microcarriers produced by such methods, methods in which such microcarriers are used to culture a cell population in a bioreactor and a system for producing microcarriers by ink jetting are also disclosed.
-
-
公开(公告)号:EP4377445A1
公开(公告)日:2024-06-05
申请号:EP22757431.6
申请日:2022-07-27
IPC分类号: C12N5/0735 , C12N5/079
-
9.
公开(公告)号:EP4377444A1
公开(公告)日:2024-06-05
申请号:EP22848834.2
申请日:2022-07-28
IPC分类号: C12N5/071 , C12M1/00 , C12N5/079 , C12N5/09 , G01N33/50 , C12M3/06 , A61L27/38 , C12N5/00 , G09B23/00 , B29C64/00 , A61F2/04 , A61L27/36
CPC分类号: G01N33/5011 , G01N33/5082 , G01N2800/5220130101 , C12M29/10 , C12M25/14 , B33Y10/00 , C12N2533/5620130101 , C12N2533/5420130101 , C12N5/0693 , C12N2502/08620130101 , C12N2502/2820130101 , C12N2503/0220130101 , C12N2501/11520130101 , C12N2537/1020130101 , G09B23/30 , G01N33/5058 , C12N2513/0020130101
-
公开(公告)号:EP4299721A3
公开(公告)日:2024-04-24
申请号:EP23208039.0
申请日:2014-05-08
申请人: ProKidney
发明人: BASU, Joydeep , BRUCE, Andrew , KELLEY, Rusty , GUTHRIE, Kelly
IPC分类号: C12N5/071
CPC分类号: C12N5/0697 , C12N2513/0020130101 , C12N2533/5420130101 , A61K35/44 , C12N2502/25620130101 , C12N2502/2820130101 , A61K35/22 , A61P13/12 , A61P43/00
摘要: Described herein are organoids comprising admixtures of selected bioactive primary renal cells and a bioactive cell population, e.g., an endothelial cell population, e.g. HUVEC cells, and methods of treating a subject in need thereof with such organoids. Further, the isolated renal cells, which may include tubular and erythropoietin (EPO)-producing kidney cell populations, and/or the endothelial cell populations may be of autologous, syngeneic, allogeneic or xenogeneic origin, or any combination thereof. Further provided are methods of treating a subject in need with the organoids.
-
-
-
-
-
-
-
-
-